Streetbeat News

Revenues

ECVT

Ecovyst has reaffirmed its fiscal year 2024 revenue forecast to be in the range of $715 million to $755 million, with an expected adjusted EBITDA of $255 million to $275 million.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:11 am

MNTX

Manitex International has reaffirmed its fiscal year 2024 revenue forecast to be in the range of $300 million to $310 million, aligning closely with the analyst estimate of $305.6 million. Additionally, the company anticipates its total adjusted EBITDA margin to be between 10.1% and 10.5%.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:08 am

EXLS

ExlService projects its FY24 revenue to be between $1.79 billion and $1.82 billion, surpassing the estimated $1.8 billion.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:07 am

CGNX

Cognex projects Q2 2024 revenue to be between $230M-$245M, indicating a sequential increase from Q1 due to typical consumer electronics seasonality. Adjusted gross margin is expected to slightly exceed 70%, up from 68.8% in Q1, with operating expenses to rise by low to mid-single digits due to investment in the Emerging Customer initiative. The adjusted effective tax rate is anticipated to be 16%.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:06 am

LXP

LXP Industrial Trust reported its Q1 2024 adjusted FFO at $0.16 per share, meeting analyst expectations, and sales of $86.251M, surpassing the $81.723M forecast. This represents a slight decrease in earnings but an increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:06 am

RSI

Rush Street Interactive shares surged following the announcement of Q1 financial results that exceeded expectations and the issuance of FY24 revenue guidance surpassing estimates.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:06 am

CI

Cigna has reaffirmed its 2024 adjusted revenue forecast, maintaining expectations of at least $235 billion, closely aligning with its previous guidance of $235.10 billion. This announcement underscores the company's confidence in its financial outlook and strategic direction.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:05 am

WCC

WESCO International has reaffirmed its fiscal year 2024 sales growth forecast to be between 1% to 4% and expects its adjusted EBITDA margin to range from 7.5% to 7.9%.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:04 am

AUPH

Aurinia Pharmaceuticals has reaffirmed its net product revenue guidance for the year 2024, projecting revenues to be in the range of $200 million to $220 million. This announcement is a significant indicator of the company's financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:04 am

CI

Cigna's total pharmacy customers increased by 25% to 122.8 million in the first quarter of 2024, compared to the end of 2023.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:02 am